Cytomegalovirus DNA Terminase Complex Inhibitor class drugs

1 result
Merck Sharp & Dohme LLC
Usage: PREVYMIS® is indicated for prophylaxis of cytomegalovirus (CMV) infection in CMV-seropositive hematopoietic stem cell transplant recipients aged 6 months and older, and for CMV disease prevention in high-risk kidney transplant recipients aged 12 years and older.